Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Child's Nervous System
Published in: Child's Nervous System 10/2011

01-10-2011 | Special Annual Issue

Hydrocephalus in neurocysticercosis

Authors: Hamilton Matushita, Fernando Campos Gomes Pinto, Daniel Dante Cardeal, Manoel Jacobsen Teixeira

Published in: Child's Nervous System | Issue 10/2011

Login to get access

Abstract

Introduction

Cysticercosis (CC) is the most important of the parasitic diseases of the central nervous system due to its high incidence in the world. CC is the infection with the larval cysts of Taenia solium. It is the most common helminthic infection of the nervous system and is endemic in most underdeveloped countries as well as in industrialized nations. It is estimated that approximately 50,000 people die every year from neurocysticercosis (NCC) worldwide.

Discussion

Humans with CC are incidental intermediate hosts, which replace the pig in the life cycle of the T. solium. Children are more frequently affected by parenchyma infestation of cysticercus, of which the main clinical manifestation is epilepsy. Hydrocephalus is more common in adults and is caused by cerebrospinal fluid blockage by ventricular cysts and inflammatory reactions (ependimitis/arachnoiditis). Treatment should be individualized based on clinical presentation, degree of infestation, location and viability of cysticercus, and host response. Hydrocephalus can be controlled only by removal of obstructive intraventricular cysts or associated with either ventriculoperitoneal shunt or endoscopic third ventriculostomy. The degree of infestation and complications related to the shunt represents the most important prognostic factors in the outcome of NCC.
Literature
1.
Agapejev S (2003) Clinical and epidemiological aspects of neurocysticercosis in Brazil: a critical approach. Arq Neuropsiquiatr 61(3B):822–828PubMedCrossRef
2.
Agapejev S, Da Silva MD, Ueda AK (1996) Severe forms of neurocysticercosis: treatment with albendazole. Arq Neuropsiquiatr 54(1):82–93PubMedCrossRef
3.
Alcala M, Hernandez-Aguilar J, Davila G, Bernal RM (2001) . Neurocysticercosis in children: A study of 100 cases. In Fukuyama Y, Kamoshita S, Otsuka C, Suzuki Y, eds. modern Perspectives of Child Neurology. Published by Japanese Society of Child Neurology p 73-93
4.
Alsina GA, Johnson JP, McBride DQ, Rhoten PR, Mehringer CM, Stokes JK (2002) Spinal neurocysticercosis. Neurosurg Focus 12(6):e8PubMedCrossRef
5.
Amaral L, Maschietto M, Maschietto R, Cury R, Ferreira NF, Mendonca R, Lima SS (2003) Unusual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases. Arq Neuropsiquiatr 61(3A):533–541PubMedCrossRef
6.
7.
Bandres JC, White AC Jr, Samo T, Murphy EC, Harris RL (1992) Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis 15(5):799–811PubMedCrossRef
8.
9.
Braga F, Rocha AJ, Gomes HR, Filho GH, Silva CJ, Fonseca RB (2004) Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis. AJNR Am J Neuroradiol 25(2):295–297PubMed
10.
Canelas HM (1962) Neurocysticercosis: incidence, diagnosis and clinical forms. Arq Neuropsiquiatr 20:1–16PubMed
11.
Cantu C, Barinagarrementeria F (1996) Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 53(3):233–239PubMed
12.
Cardenas YCJ (1962) Cysticercosis of central nervous system: II. Pathologic and radiologic findings. J Neurosurg 19:635CrossRef
13.
14.
Carpio A, Escobar A, Hauser WA (1998) Cysticercosis and epilepsy: a critical review. Epilepsia 39(10):1025–1040PubMedCrossRef
15.
Chimelli L, Lovalho AF, Takayanagui OM (1998) Neurocysticercosis: contribution of autopsies in the consolidation of mandatory notification in Ribeirao Preto—SP, Brazil. Arq Neuropsiquiatr 56(3B):577–584PubMedCrossRef
16.
Colli BO, Carlotti CG Jr, Assirati JA Jr, Machado HR, Valenca M, Amato MC (2002) Surgical treatment of cerebral cysticercosis: long-term results and prognostic factors. Neurosurg Focus 12(6):e3PubMed
17.
18.
Couldwell WT, Zee CS, Apuzzo ML (1991) Definition of the role of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri. Neurosurgery 28(2):231–237PubMedCrossRef
19.
Cuetter AC, Andrews RJ (2002) Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature. Neurosurg Focus 12(6):e5PubMedCrossRef
20.
Cuetter AC, Garcia-Bobadilla J, Guerra LG, Martinez FM, Kaim B (1997) Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis 24(2):157–164PubMedCrossRef
21.
Del Brutto OH (1994) Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44(9):1706–1709PubMed
22.
Del Brutto OH, Campos X, Sanchez J, Mosquera A (1999) Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology 52(5):1079–1081PubMed
23.
Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, Schantz PM, Evans CA, Flisser A, Correa D, Botero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, Garcia HH (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57(2):177–183PubMed
24.
DeGiorgio CM, Houston I, Oviedo S, Sorvillo F (2001) Deaths associated with cysticercosis. Report of three cases and review of the literature. Neurosurg Focus 12(6):e2.
25.
do Amaral LL, Ferreira RM, da Rocha AJ, Ferreira NP (2005) Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging 16(2):127–144PubMedCrossRef
26.
Escobar A (1983) the pathology of neuroxysticercosis. In: Palacios EE, Rodrigues-Carbajal J, Taveras JM (eds) Cysticercosi of central nervous system. Thomas, Springfield, p 23
27.
Estanol B, Kleriga E, Loyo M, Mateos H, Lombardo L, Gordon F, Saguchi AF (1983) Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy. Neurosurgery 13(2):119–123PubMedCrossRef
28.
29.
30.
Flisser A, Sarti E, Lightowlers M, Schantz P (2003) Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop 87(1):43–51PubMed
31.
32.
33.
Garcia HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, Rajshekhar V, Tsang VC, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez AE, Gilman RH, Del Brutto OH (2002) Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15(4):747–756PubMedCrossRef
34.
Garcia HH, Gilman RH, Horton J, Martinez M, Herrera G, Altamirano J, Cuba JM, Rios-Saavedra N, Verastegui M, Boero J, Gonzalez AE (1997) Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology 48(5):1421–1427PubMed
35.
36.
37.
38.
Gekeler F, Eichenlaub S, Mendoza EG, Sotelo J, Hoelscher M, Loscher T (2002) Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis. Eur J Clin Microbiol Infect Dis 21(3):227–229. doi:10.​1007/​s10096-002-0695-3 PubMedCrossRef
39.
Gravori T, Steineke T, Bergsneider M (2002) Endoscopic removal of cisternal neurocysticercal cysts. Technical note. Neurosurg Focus 12(6):e7PubMedCrossRef
40.
41.
Itabashi HH (1983) Pathology of CNS cysticercosis. Bull Clin Neurosci 48:6–17PubMed
42.
43.
Kalra V, Suri M, Jailkhani BL (1994) A profile of childhood neurocysticercosis. Indian J Pediatr 61(1):33–42PubMedCrossRef
44.
Kelley R, Duong DH, Locke GE (2002) Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery 50(4):757–761, discussion 761–752PubMedCrossRef
45.
Ko DY, Chang GY (1998) Albendazole therapy for neurocysticercosis. Neurology 50(3):834–835PubMed
46.
Lefevre AB (1966) Clinical study of intracranial tumors in children. Considerations on 127 cases. Rev Hosp Clin Fac Med Sao Paulo 21(1):1–31PubMed
47.
48.
49.
Lopez-Hernandez A (1983) Clinical manifestations and sequential computed tomography scans of cerebral cysticercosis in childhood. Brain Dev 5(3):269–277PubMed
50.
Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado LR, Leite CC (2007) The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: impact on characterization of the scolex and lesion burden. AJNR Am J Neuroradiol 28(8):1501–1504. doi:10.​3174/​ajnr.​A0623 PubMedCrossRef
51.
Madrazo I, Garcia-Renteria JA, Sandoval M, Lopez Vega FJ (1983) Intraventricular cysticercosis. Neurosurgery 12(2):148–152PubMedCrossRef
52.
53.
MLG M (1990) Neurocisticercose na infância: aspectos de correlações clinicas e tomográficas (tese de doutorado). Faculdade de Medicina da Universidade de São Paulo, São Paulo
54.
MLG M (1996) Neurocisticercose na infancia. Aspectos terapeuticos. Machado LR, Livramento JA, Spina FN, Nobrega JPS (eds) Neuroinfecção 96 São Paulo: Clinica Neurologica HC/FMUSP:219
55.
Morales NM, Agapejev S, Morales RR, Padula NA, Lima MM (2000) Clinical aspects of neurocysticercosis in children. Pediatr Neurol 22(4):287–291PubMedCrossRef
56.
Neal JH (1995) An endoscopic approach to cysticercosis cysts of the posterior third ventricle. Neurosurgery 36(5):1040–1043PubMedCrossRef
57.
58.
NJ C (1995) Epidemiological status of the taeniasis/cysticercosis in the State of Paraná (south region of Brazil) and the control strategies. Taeniasis/cysticercosis complex: future trends towards its control. PAHO/WHO
59.
Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, Pinner RW (2002) Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8(6):608–613PubMed
60.
Pfuetzenreiter MR, de Avila-Pires FD (1999) Clinical manifestations in patients with computerized tomography diagnosis of neurocysticercosis. Arq Neuropsiquiatr 57(3A):653–658PubMedCrossRef
61.
62.
Proano JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I (2001) Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 345(12):879–885. doi:10.​1056/​NEJMoa010212 PubMedCrossRef
63.
64.
Proano JV, Torres-Corzo J, Rodriguez-Della Vecchia R, Guizar-Sahagun G, Rangel-Castilla L (2009) Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst 25(11):1467–1475. doi:10.​1007/​s00381-009-0933-4 PubMedCrossRef
65.
Raffin LS, Bacheschi LA, Machado LR, Nobrega JP, Coelho C, Leite CC (2001) Diffusion-weighted MR imaging of cystic lesions of neurocysticercosis: a preliminary study. Arq Neuropsiquiatr 59(4):839–842PubMedCrossRef
66.
Rajshekhar V, Jeyaseelan L (2004) Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 62(12):2236–2240PubMed
67.
Rangel-Castilla L, Serpa JA, Gopinath SP, Graviss EA, Diaz-Marchan P, White AC Jr (2009) Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg 80(3):373–378PubMed
68.
Rodriguez-Carbajal J, Boleaga-Duran B, Dorfsman J (1987) The role of computed tomography (CT) in the diagnosis of neurocysticercosis. Childs Nerv Syst 3(4):199–202PubMedCrossRef
69.
70.
Salgado P, Rojas R, Sotelo J (1997) Cysticercosis. Clinical classification based on imaging studies. Arch Intern Med 157(17):1991–1997PubMedCrossRef
71.
Schantz PM, Sarti E, Plancarte A, Wilson M, Criales JL, Roberts J, Flisser A (1994) Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 18(6):879–885PubMedCrossRef
72.
Schantz PM Wilkins PP, Tsang VCW (1998) Immigrants, imaging, and immunoblots: the emergence of neurocysticercosis as a major public health problem. In: Scheld WM, Craig WA, Hughes JM (eds) Emerging infections 2. ASM, Washington, pp. 213–242
73.
Schenone HVF, Rojas A, Ramirez R (1982) Epidemiology of humans cysticercosis in Latin America. In: Flisser A, Willms K, Laclette JP, Larralde C (eds) Cysticercosis: present state of knowledge and perspectives. Academic, New York, pp 25–38
74.
Shandera WX, White AC Jr, Chen JC, Diaz P, Armstrong R (1994) Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore) 73(1):37–52
75.
Sorvillo FJ, DeGiorgio C, Waterman SH (2007) Deaths from cysticercosis, United States. Emerg Infect Dis 13(2):230–235PubMedCrossRef
76.
77.
78.
79.
Sotelo J, Torres B, Rubio-Donnadieu F, Escobedo F, Rodriguez-Carbajal J (1985) Praziquantel in the treatment of neurocysticercosis: long-term follow-up. Neurology 35(5):752–755PubMed
80.
81.
82.
Suri A, Goel RK, Ahmad FU, Vellimana AK, Sharma BS, Mahapatra AK (2008) Endoscopic excision of intraventricular neurocysticercosis in children: a series of six cases and review. Childs Nerv Syst 24(2):281–285. doi:10.​1007/​s00381-007-0462-y PubMedCrossRef
83.
Suri A, Goel RK, Ahmad FU, Vellimana AK, Sharma BS, Mahapatra AK (2008) Transventricular, transaqueductal scope-in-scope endoscopic excision of fourth ventricular neurocysticercosis: a series of 13 cases and a review. J Neurosurg Pediatr 1(1):35–39. doi:10.​3171/​PED-08/​01/​035 PubMedCrossRef
84.
Takayanagui OM (1990) Neurocysticercosis. I. Clinical and laboratory course of 151 cases. Arq Neuropsiquiatr 48(1):1–10PubMed
85.
Takayanagui OM, Castro e Silva AA, Santiago RC, Odashima NS, Terra VC, Takayanagui AM (1996) Compulsory notification of cysticercosis in Ribeirao Preto—SP, Brazil. Arq Neuropsiquiatr 54(4):557–564PubMedCrossRef
86.
Takayanagui OM, Jardim E (1983) Clinical aspects of neurocysticercosis: analysis of 500 cases. Arq Neuropsiquiatr 41(1):50–63PubMed
87.
Thussu A, Sehgal S, Sharma M, Lal V, Sawhney IM, Prabhakar S (1997) Comparison of cellular responses in single- and multiple-lesion neurocysticercosis. Ann Trop Med Parasitol 91(6):627–632PubMedCrossRef
88.
89.
Tsang VC, Brand JA, Boyer AE (1989) An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159(1):50–59PubMedCrossRef
90.
Wallin MT, Kurtzke JF (2004) Neurocysticercosis in the United States: review of an important emerging infection. Neurology 63(9):1559–1564PubMed
91.
White AC Jr (1997) Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 24(2):101–113, quiz 114–105PubMedCrossRef
92.
93.
Zee CS, Segall HD, Destian S, Ahmadi J, Apuzzo ML (1993) MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr 17(6):932–939PubMedCrossRef
94.
Zymberg ST, Paiva Neto MA, Gorgulho AA, Cavalheiro S (2003) Endoscopic approach to fourth ventricle cysticercosis. Arq Neuropsiquiatr 61(2A):204–207PubMedCrossRef
Metadata
Title
Hydrocephalus in neurocysticercosis
Authors
Hamilton Matushita
Fernando Campos Gomes Pinto
Daniel Dante Cardeal
Manoel Jacobsen Teixeira
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 10/2011
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-011-1500-3

Other articles of this Issue 10/2011

Child's Nervous System 10/2011 Go to the issue

Special Annual Issue

Hydrocephalus in aqueductal stenosis

Special Annual Issue

Fetal ventriculomegaly: postnatal management

Special Annual Issue

Guideline for management and treatment of fetal and congenital hydrocephalus: Center Of Excellence—Fetal and Congenital Hydrocephalus Top 10 Japan Guideline 2011

Special Annual Issue

Congenital hydrocephalus associated with myeloschisis

Special Annual Issue

A consensus on the classification of hydrocephalus: its utility in the assessment of abnormalities of cerebrospinal fluid dynamics

Special Annual Issue

Hydrocephalus and spinal cord tumors: a review